Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01184469 · ClinicalTrials.gov registry record
Prospective Observational Study of Peri-implantation Serum hCG Levels
A clinical trial, sponsored by Bruce Shapiro M.D..
- Completed
- Registry status
- 451
- Enrollment target
NCT01184469: Completed study, sponsored by Bruce Shapiro M.D..
NCT01184469 is a clinical trial that has completed, run by Bruce Shapiro M.D.. The registered enrollment target is 451 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01184469 has completed, sponsored by Bruce Shapiro M.D..
- COMPLETED
- Registry status
- 451 participants
- Enrollment target
Study Summary
The purpose of this study is to prospectively define a set of data suitable for developing models of pregnancy viability. Those models will be based on serum hCG concentration measured during the peri-implantation period in patients that received fresh embryo transfer and those that received transfer of frozen-thawed embryos, and to compare and contrast these models. This may reveal insights into differences between these types of IVF cycles.
Primary Outcome
Fetal heart motion at 10 weeks gestation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 451 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-05 |
What the finished NCT01184469 record still lists
NCT01184469 is an observational study that tracks outcomes without assigning an intervention. The registered 451 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01184469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01184469 about?
NCT01184469 is a clinical study titled "Prospective Observational Study of Peri-implantation Serum hCG Levels". The purpose of this study is to prospectively define a set of data suitable for developing models of pregnancy viability. Those models will be based on serum hCG concentration measured during the peri-implantation period in patients that received fresh embryo transfer and those that received transfe...
What is the current status of trial NCT01184469?
This trial is currently completed. The enrollment target is 451 participants. The study started on 2010-08. Estimated completion is 2012-05.
Who is sponsoring clinical trial NCT01184469?
This trial is sponsored by Bruce Shapiro M.D., which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05676255 · 452 participants · Phase 2
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- NCT05703178 · 452 participants · Phase 3
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia